Results 141 to 150 of about 246,923 (261)

The National Allergy Centre of Excellence–Addressing Australia's Allergy Burden

Clinical &Experimental Allergy, EarlyView.
Australia's high allergy burden prompted a national response, leading to the establishment of the National Allergy Centre of Excellence (NACE) in 2022. The NACE has advanced research infrastructure, collaboration, and consumer‐centred care through four pillars, achieving global recognition and accelerating translation into policy, practice, and ...
A. Young, J. J. Koplin, D. E. Campbell, J. M. Davies, H. Edmund, T. Jamieson, C. J. Hornung, T. O'Farrell, D. West, E. Kayes, L. A. Gray, R. L. Peters, L. Gamble, K. Gwynne, J. Lee, M. Lucas, C. H. Katelaris, M. D. O'Sullivan, D. J. Palmer, J. Trubiano, S. van Nunen, S. L. Vale, T. Wanandy, K. P. Perrett   +23 more
wiley   +1 more source

Peptide Allergen Immunotherapy: A New Perspective in Olive-Pollen Allergy. [PDF]

Pharmaceutics, 2021
Calzada D, Cremades-Jimeno L, López-Ramos M, Cárdaba B.   +3 more
europepmc   +1 more source

Grass pollen allergy in children and adolescents-symptoms, health related quality of life and the value of pollen prognosis

, 2013
Introduction An association between pollen count (Poaceae) and symptoms is well known, but to a lesser degree the importance of priming and lag effects. Also, threshold levels for changes in symptom severity need to be validated.
Tunsäter, Alf,, Jacobsson, Helene, Cilio, Corrado M, Dahl, Åslög,, Kiotseridis, Hampus, Bjermer, Leif   +5 more
core  

Allergic disease--pollen allergy and climate change

, 2009
Pollen allergy currently affects a fifth of the population. A warmer climate will lead to a longer pollen season and more days with high pollen counts.
Plaschke, Peter, Sommer, Janne, Poulsen, Lars K   +2 more
core   +1 more source

Need to Assess On‐Demand Versus Continuous Treatment in Allergic Rhinitis in ARIA‐EAACI Guidelines

Allergy, EarlyView.
Jean Bousquet, Bernardo Sousa‐Pinto, Maria J. Torres, Mario Morais‐Almeida, Ludger Klimek, Giorgio Ciprandi, Robert Naclerio, Torsten Zuberbier   +7 more
wiley   +1 more source

Subcutaneous Allergen Immunotherapy With Thermosensitive Hydrogel and Recombinant Birch Pollen Allergen Variant, a Randomised Controlled Trial

Clinical &Experimental Allergy, EarlyView.
A Phase 1, randomised, placebo‐controlled, dose‐escalation trial was performed with 30 birch pollen allergic subjects treated with DM‐101PX, that contains a recombinant hypoallergenic variant of Bet v 1 formulated with poloxamer 338 thermosensitive hydrogel.
Anna Nilson, Patricia Couroux, Jaana Haka, Silja Halme, Pekka Mattila, R. J. Joost van Neerven, Rolien Pels‐Rijcken, Janneke Ruinemans‐Koerts, Yvonne Schmidt‐Hieltjes, Anne Marie Salapatek, Kati Sallinen, Kristiina Takkinen, Daphne Tsitoura, Dirk‐Jan Opstelten, Juha Rouvinen   +14 more
wiley   +1 more source

Face masks suitable for preventing COVID-19 and pollen allergy. A study in the exposure chamber. [PDF]

Allergo J Int, 2021
Bergmann KC, Kugler S, Zuberbier T, Becker S.   +3 more
europepmc   +1 more source

High Specificity of sIgE to α−/β‐Gliadin and Limited Reactivity to Non‐Gluten Proteins in Wheat Allergy Dependent on Augmentation Factors (WALDA)

Clinical &Experimental Allergy, EarlyView.
This study suggest that WALDA is characterized by highly specific reactivity to gliadin proteins, with limited sensitization to non‐gluten wheat components. sIgE to α‐/β‐gliadin represents a promising diagnostic biomarker with superior specificity compared to ω5‐gliadin alone.
Valentina Faihs, Florian Schusta, Claudia Kugler, Tilo Biedermann, Monika Raulf, Margitta Worm, Knut Brockow, Ingrid Sander   +7 more
wiley   +1 more source

Symptom patterns and comparison of diagnostic methods in ragweed pollen allergy. [PDF]

Exp Ther Med, 2021
Haidar L, Tamas TP, Stolz F, Patrascu RFP, Chen KW, Panaitescu C.   +5 more
europepmc   +1 more source

Effects of a Cloth Panel Containing a Specific Ore Powder on Patients with Chamaecyparis obtusa (Cypress) Pollen Allergy. [PDF]

ScientificWorldJournal, 2021
Lee S, Hyo Y, Yamamoto S, Okamoto H, Fujii Y, Hara H, Otsuki T.   +6 more
europepmc   +1 more source